NCT06843889 2025-04-16A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaNanfang Hospital, Southern Medical UniversityPhase 2 Recruiting34 enrolled
NCT03474640 2024-11-22Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced MalignanciesTopAlliance BiosciencesPhase 1 Completed184 enrolled 20 charts
NCT05996484 2023-08-21Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal CarcinomaNanfang Hospital, Southern Medical UniversityPhase 2 Not yet recruiting25 enrolled